← Leaderboards
Richard M Stone
Dana-Farber Cancer Inst
$3,984,410
Attributed
$4,934,541
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2008–24$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$15,579,231 · 13
By mechanism
P50$11,112,510 · 6
P01$4,412,221 · 3
R13$54,500 · 4
Top collaborators
- Benjamin Levine Ebert11 shared
- James D Griffin5 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Benjamin Levine Ebert$26,802,844
- Jun Qi$6,834,111
- Kenneth James Livak$2,617,128
- Roger Vincent Belizaire$1,076,976
- David Marc Weinstock$10,844,261
Others in their field
Top investigators on “Laboratories”
- David Heimbrook · Leidos Biomedical Research, Inc.$943,075,715
- Lawrence Corey · Fred Hutchinson Cancer Center$747,603,944
- Jeffrey P Krischer · University Of South Florida$627,303,958
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$553,634,937
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
Research focus
LaboratoriesResearch PersonnelClinical TrialsPre-ClinicalClinical ResearchLeadRelapseResearch SupportAncillary StudyMyeloid LeukemiaEnsurePharmacologic SubstanceNovel TherapeuticsResourcesGrantHospitalsDiagnosisCellsDesignPathway InteractionsLeukemiaSamplingPhysiciansScientist
Grant awards (30)
Clinical Research Support$304,767
P01 · FY2024 · CA · contact PI
Clinical Research Support$318,053
P01 · FY2023 · CA · contact PI
Clinical Research Support$312,435
P01 · FY2022 · CA · contact PI
SPORE in Myeloid Malignancies$2,138,999
P50 · FY2021 · CA
Clinical Research Support$318,812
P01 · FY2021 · CA · contact PI
SPORE in Myeloid Malignancies$1,881,692
P50 · FY2020 · CA
Clinical Research Support$325,313
P01 · FY2020 · CA · contact PI
SPORE in Myeloid Malignancies$2,138,999
P50 · FY2019 · CA
SPORE in Myeloid Malignancies$1,440,214
P50 · FY2018 · CA
SPORE in Myeloid Malignancies$859,786
P50 · FY2018 · CA
Clinical Research Support Core$284,698
P01 · FY2018 · CA · contact PI
Project-005$222,500
P50 · FY2018 · CA
Project-007$126,009
P50 · FY2018 · CA
Core-004$67,906
P50 · FY2018 · CA
Admin-Core-002$33,422
P50 · FY2018 · CA
Project-006$17,983
P50 · FY2018 · CA
SPORE in Myeloid Malignancies$2,185,000
P50 · FY2017 · CA
Clinical Research Support Core$284,685
P01 · FY2017 · CA · contact PI
Clinical Research Support Core$284,672
P01 · FY2016 · CA · contact PI
2016 Bone Marrow Failure Disease Scientific Symposium$10,000
R13 · FY2016 · HL · contact PI
Clinical Research Support Core$284,644
P01 · FY2015 · CA · contact PI
Clinical Research Support Core$293,743
P01 · FY2014 · CA · contact PI
2014 Bone Marrow Failure Disease Scientific Symposium$5,000
R13 · FY2014 · HL · contact PI
CLINICAL TRIALS IN MYELOID MALIGANANCIES WITH MOLECULARLY TARGETED THERAPIES$278,836
P01 · FY2012 · CA · contact PI
Third Bone Marrow Failure Disease Scientific Symposium$12,500
R13 · FY2012 · HL · contact PI
CLINICAL TRAILS IN MYELOID MALIGANANCIES WITH MOLECULARLY TARGETED THERAPIES$277,116
P01 · FY2011 · CA · contact PI
CLINICAL TRAILS IN MYELOID MALIGANANCIES WITH MOLECULARLY TARGETED THERAPIES$287,075
P01 · FY2010 · CA · contact PI
CLINICAL TRAILS IN MYELOID MALIGANANCIES WITH MOLECULARLY TARGETED THERAPIES$282,700
P01 · FY2009 · CA · contact PI
AA&MDSIF Second Bone Marrow Failure Disease Scientific Symposium$27,000
R13 · FY2009 · HL · contact PI
CLINICAL TRAILS IN MYELOID MALIGANANCIES WITH MOLECULARLY TARGETED THERAPIES$274,672
P01 · FY2008 · CA · contact PI